Ameriprise Financial Inc Genmab A/S Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $184,904 - $229,258	6,996 New	6,996 $209,000
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $11,885 - $14,234	337 Added 5.68%	6,268 $221,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $22,477 - $25,806	601 Added 11.28%	5,931 $225,000
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $7,952 - $9,854	-228 Reduced 4.1%	5,330 $201,000
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $187,860 - $261,559	5,558 New	5,558 $235,000
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $152,099 - $218,653	-5,669 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $210,831 - $270,300	-6,812 Reduced 54.58%	5,669 $205,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $237,567 - $312,075	6,623 Added 113.06%	12,481 $494,000
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $9,639 - $11,303	232 Added 4.12%	5,858 $255,000
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $46,590 - $63,155	-1,417 Reduced 20.12%	5,626 $230,000
Q1 2021 May 17, 2021	SELL	$30.92 - $44.4 $906,698 - $1.3 Million	-29,324 Reduced 80.63%	7,043 $232,000
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $94,584 - $114,535	2,810 Added 8.37%	36,367 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $911,376 - $1.07 Million	27,559 Added 459.47%	33,557 $1.23 Million
Q2 2020 Aug 14, 2020	SELL	$20.05 - $33.89 $723,223 - $1.22 Million	-36,071 Reduced 85.74%	5,998 $204,000
Q1 2020 May 15, 2020	BUY	$17.15 - $25.22 $13,651 - $20,075	796 Added 1.93%	42,069 $891,000
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $7,948 - $10,162	421 Added 1.03%	41,273 $921,000
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $735,336 - $873,415	40,852 New	40,852 $827,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account